| SCZ Cohort (N = 102,207) | Non-SCZ Cohort (N = 102,207) | SMD | Young Adult SCZ Cohort (N = 11,699) | Young Adult Non-SCZ Cohort (N = 11,699) | SMD |
---|---|---|---|---|---|---|
Age at Index (years) | ||||||
 Mean (SD) | 56.7 (13.8) | 57.7 (16.3) | −0.06 | 29.7 (3.7) | 30.7 (4.2) | −0.25 |
 Median (IQR) | 59 (50–66) | 59 (47–67) |  | 30 (27–33) | 31 (28–33) |  |
Age Categories, n , (%) | Â | Â | 0.10 | Â | Â | 0.00 |
 18–34 | 10,205 (10.0%) | 11,641 (11.4%) |  | 10,613 (90.8%) | 10,610 (90.7%) |  |
 35–44 | 8774 (8.6%) | 11,314 (11.1%) |  | 1086 (9.3%) | 1089 (9.3%)b |  |
 45–54 | 16,798 (16.4%) | 16,022 (15.7%) |  | NA | NA |  |
 55–64 | 35,154 (34.4%) | 31,908 (31.2%) |  | NA | NA |  |
  ≥ 65 | 31,276 (30.6%) | 31,322 (30.6%) |  | NA | NA |  |
Male Gender, n , (%) | 93,100 (91.1%) | 92,469 (90.5%) | 0.02 | 10,182 (87.0%) | 10,202 (87.2%) | −0.01 |
Race, n , (%) | Â | Â | 0.08 | Â | Â | 0.11 |
 White | 62,724 (61.4%) | 62,889 (61.5%) |  | 6801 (58.1%) | 6782 (58.0%) |  |
 Black | 29,562 (28.9%) | 28,979 (28.4%) |  | 3513 (30.1%) | 3411 (29.2%) |  |
 Hawaiian Pacific islander | 1233 (1.2%) | 1187 (1.2%) |  | 172 (1.5%) | 180 (1.5%) |  |
 Asian | 886 (0.9%) | 1238 (1.2%) |  | 308 (2.6%) | 424 (3.6%) |  |
 Native American | 745 (0.7%) | 874 (0.9%) |  | 118 (1.0%) | 131 (1.1%) |  |
 Unknown/ Decline | 7057 (7.0%) | 7040 (6.9%) |  | 787 (6.7%) | 771 (6.6%) |  |
US Geographic Region, n , (%) | Â | Â | 0.03 | Â | Â | 0.03 |
 South | 33,377 (32.7%) | 33,796 (33.1%) |  | 3677 (31.4%) | 3633 (31.1%) |  |
 Northeast | 26,385 (25.9%) | 25,294 (24.8%) |  | 2443 (20.9%) | 2398 (20.5%) |  |
 Midwest | 20,683 (20.3%) | 21,847 (21.4%) |  | 2609 (22.3%) | 2645 (22.6%) |  |
 West | 21,762 (21.3%) | 21,270 (20.9%) |  | 2970 (25.4%) | 3023 (25.8%) |  |
Urban Residence, n , (%) | 75,671 (74.0%) | 74,996 (73.4%) | 0.02 | 9046 (77.3%) | 9124 (78.0%) | −0.02 |
Charlson Comorbidity Index | ||||||
 Mean (SD) | 1.8 (2.3) | 1.7 (2.4) | 0.02 | 0.3 (0.7) | 0.3 (0.7) | 0.01 |
 Median (IQR) | 1 (0–3) | 1 (0–3) |  | 0 (0–0) | 0 (0–0) |  |
Comorbidities of Interest, n , (%) | ||||||
 Substance use disorder | 43,096 (42.2%) | 25,482 (24.9%) | 0.37 | 5762 (49.3%) | 2756 (23.6%) | 0.55 |
 Mental health conditions of interest (Any) | 30,176 (29.5%) | 14,980 (14.7%) | 0.36 | 5699 (48.7%) | 3208 (27.4%) | 0.45 |
  PTSD | 17,772 (17.4%) | 9213 (9.0%) | 0.25 | 3671 (31.4%) | 2163 (18.5%) | 0.30 |
  Anxiety | 12,622 (12.3%) | 5717 (5.6%) | 0.24 | 2452 (21.0%) | 1125 (9.6%) | 0.32 |
  Suicide ideation | 5554 (5.4%) | 218 (0.2%) | 0.32 | 1303 (11.1%) | 34 (0.3%) | 0.48 |
  Suicide attempt | 640 (0.6%) | 39 (0.0%) | 0.10 | < 11a | < 11 a | – |
 Hypertension | 29,684 (29.0%) | 28,142 (27.5%) | 0.03 | 484 (4.1%) | 334 (2.9%) | 0.07 |
 Hyperlipidemia | 27,243 (26.7%) | 24,504 (24.0%) | 0.06 | 832 (7.1%) | 514 (4.4%) | 0.12 |
 Diabetes | 21,856 (21.4%) | 21,519 (21.1%) | 0.01 | 243 (2.1%) | 225 (1.9%) | 0.01 |
 Obesity | 10,172 (10.0%) | 8053 (7.9%) | 0.07 | 791 (6.8%) | 496 (4.3%) | 0.11 |
 Coronary artery disease | 6252 (6.1%) | 8489 (8.3%) | −0.08 | 11 (0.1%) | 18 (0.2%) | −0.02 |
 Hepatitis | 5405 (5.3%) | 2932 (2.9%) | 0.12 | 143 (1.3%) | 50 (0.4%) | 0.09 |
 Liver disease | 4249 (4.2%) | 3092 (3.0%) | 0.06 | 148 (1.3%) | 83 (0.7%) | 0.06 |
 Cancer | 2902 (2.8%) | 4942 (4.8%) | −0.10 | 27 (0.2%) | 59 (0.5%) | −0.05 |
 Congestive heart failure | 2917 (2.9%) | 3839 (3.8%) | −0.05 | 21 (0.2%) | 15 (0.1%) | 0.01 |
PHQ-2 score, c n , (%) | 60,596 (59.3%) | 71,602 (70.1) | Â | 5961 (51.0%) | 7689 (65.7%) | Â |
 Mean (SD) | 1.1 (1.7) | 0.5 (1.2) | 0.41 | 1.8 (2.1) | 0.8 (1.5) | 0.58 |
 Median (IQR) | 0 (0–2) | 0 (0) |  | 1 (0–3) | 0 (0–1) |  |